Atlantic Therapeutics: Non-Invasive Treatment for Stress Urinary Incontinence

article image

Stress urinary incontinence affects 30% of women and some men as well, but most don’t seek help because they believe there is no helpful treatment. The founders of Atlantic Therapeutics hope to meet that pent-up demand with a wearable neuromodulation device. By Annie Keller

It’s a problem that affects one in three women, but it’s rarely talked about.


This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Sign up for All-Access

Join our global community with a subscription to both MedTech Strategist and Market Pathways for one low price.



We're here to help! Please contact us at: